John F Crowley - Net Worth and Insider Trading

John F Crowley Net Worth

The estimated net worth of John F Crowley is at least $6 Million dollars as of 2025-03-04. John F Crowley is the Executive Chairman of Amicus Therapeutics Inc and owns about 638,373 shares of Amicus Therapeutics Inc (FOLD) stock worth over $6 Million. John F Crowley is the Director of Entrada Therapeutics Inc and owns about 37,864 shares of Entrada Therapeutics Inc (TRDA) stock worth over $420,669. John F Crowley is also the Director of Intellia Therapeutics Inc and owns about 2,094 shares of Intellia Therapeutics Inc (NTLA) stock worth over $19,160. Details can be seen in John F Crowley's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John F Crowley has not made any transactions after 2024-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of John F Crowley

To

John F Crowley Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John F Crowley owns 3 companies in total, including Intellia Therapeutics Inc (NTLA) , Amicus Therapeutics Inc (FOLD) , and Entrada Therapeutics Inc (TRDA) .

Click here to see the complete history of John F Crowley’s form 4 insider trades.

Insider Ownership Summary of John F Crowley

Ticker Comapny Transaction Date Type of Owner
NTLA Intellia Therapeutics Inc 2021-10-11 director
FOLD Amicus Therapeutics Inc 2024-03-01 director & Executive Chairman
TRDA Entrada Therapeutics Inc 2022-01-12 director

John F Crowley Latest Holdings Summary

John F Crowley currently owns a total of 3 stocks. Among these stocks, John F Crowley owns 638,373 shares of Amicus Therapeutics Inc (FOLD) as of March 1, 2024, with a value of $6 Million and a weighting of 93.02%. John F Crowley owns 37,864 shares of Entrada Therapeutics Inc (TRDA) as of January 12, 2022, with a value of $420,669 and a weighting of 6.68%. John F Crowley also owns 2,094 shares of Intellia Therapeutics Inc (NTLA) as of October 11, 2021, with a value of $19,160 and a weighting of 0.3%.

Latest Holdings of John F Crowley

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FOLD Amicus Therapeutics Inc 2024-03-01 638,373 9.18 5,860,200
TRDA Entrada Therapeutics Inc 2022-01-12 37,864 11.11 420,669
NTLA Intellia Therapeutics Inc 2021-10-11 2,094 9.15 19,160

Holding Weightings of John F Crowley


John F Crowley Form 4 Trading Tracker

According to the SEC Form 4 filings, John F Crowley has made a total of 86 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years, including 0 buys and 86 sells. The most-recent trade in Amicus Therapeutics Inc is the sale of 29,181 shares on March 1, 2024, which brought John F Crowley around $389,566.

According to the SEC Form 4 filings, John F Crowley has made a total of 1 transactions in Entrada Therapeutics Inc (TRDA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Entrada Therapeutics Inc is the acquisition of 5,000 shares on January 12, 2022, which cost John F Crowley around $48,600.

According to the SEC Form 4 filings, John F Crowley has made a total of 2 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 2,500 shares on October 11, 2021, which brought John F Crowley around $298,875.

Insider Trading History of John F Crowley

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John F Crowley Trading Performance

GuruFocus tracks the stock performance after each of John F Crowley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John F Crowley is -19.7%. GuruFocus also compares John F Crowley's trading performance to market benchmark return within the same time period. The performance of stocks bought by John F Crowley within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John F Crowley's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John F Crowley

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.38 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 3.72 LIMIT LIMIT LIMIT LIMIT LIMIT

John F Crowley Ownership Network

Ownership Network List of John F Crowley

No Data

Ownership Network Relation of John F Crowley

Insider Network Chart

John F Crowley Owned Company Details

What does Intellia Therapeutics Inc do?

Who are the key executives at Intellia Therapeutics Inc?

John F Crowley is the director of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Business Officer Derek Hicks , EVP & Chief Scientific Officer Laura Sepp-lorenzino , and EVP & Chief Technical Officer Eliana Clark .

Intellia Therapeutics Inc (NTLA) Insider Trades Summary

Over the past 18 months, John F Crowley made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 16,773 shares made by Laura Sepp-lorenzino , a net sale of 12,991 shares made by Eliana Clark , and a net sale of 46,030 shares made by John M. Leonard .

In summary, during the past 3 months, insiders sold 68,521 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 68,521 shares. During the past 18 months, 123,236 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 123,236 shares.

Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intellia Therapeutics Inc Insider Transactions

No Available Data

John F Crowley Mailing Address

Above is the net worth, insider trading, and ownership report for John F Crowley. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, John F Crowley's mailing address is: Cranbury Nj 08512.